Here is my Q&A with Joe on 10/15/2019 asking about the NGIO rights offering, that never happened. Also about the top tier investment bank, which he wouldn't name because they all want $50K to use their name.
Quote:Steve: Okay. So, is that right offering then, since you mentioned during your
commentary, initially, the rights offering will provide capital structure for
NGIO? So, will that rights offering come before the end of November for the
possible uplisting you're looking at?
Operator: Well, my preference would be to do it simultaneous to the listing and the
stock trading. But again, I have to speak to legal on that as well as come up
with the best path for a rights offering with the investment bank that, at least,
that specialize rights offering. So, I really need to... that's just so new that we
haven't yet devised a--
Steve: Are you able to tell us who the investment banker is?
Joe: Investments banks don't like you when you tell who you're dealing with. I
mean Generex has an investment bank, it's a top-tier bank... I have to ask
permission to use their name, just like when I get a phrase below our sign,
"We've used one the biggest and best." I couldn't use their names unless I've
paid the $50,000 to use their name.
2
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Disclaimer: Of course, all of this is my opinion and you should not make any investment decisions based on my opinion. I have not received any non-public information.
